Invasive lobular breast carcinomas (ILBCs) represent 10–15% of all invasive breast tumors and, in the majority of cases, express hormone receptors [estrogen receptor (ER) and progesterone receptor (PR)] and lack HER2 protein expression and/or gene amplification [1]. This evidence concerns the gene ERBB2 and invasive lobular breast carcinoma.